The kidney and hypertension: Pathogenesis of salt-sensitive hypertension

Current Hypertension Reports

Volumn 14, Issue 5, 2012, Pages 468-472

  Shimosawa, Tatsuo ^a,b   Mu, Shengyu ^a,b   Shibata, Shigeru ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

2 adrenoceptor; Angiotensin II; Blood pressure; Distal tubule; ENaC; Epigenetics; Glucocorticoid receptor; HDAC8; Histone acetylation; Hypertension; Kidney; Mineralocorticoid receptor; MR; NCC; Oxidative stress; Rac1; Renal injury; RhoGDI; Roximal tubule; Salt sensitive hypertension; SgK1; Sympathetic nerve; WNK4

Indexed keywords

ALDOSTERONE; BETA 2 ADRENERGIC RECEPTOR; GLUCOCORTICOID RECEPTOR; GUANOSINE TRIPHOSPHATASE; HISTONE; HISTONE DEACETYLASE 8; MINERALOCORTICOID RECEPTOR; PROTEIN KINASE WNK4; RAC1 PROTEIN; SODIUM; SODIUM CHLORIDE COTRANSPORTER;

ADRENERGIC STIMULATION; BRAIN REGION; DISEASE ASSOCIATION; DISEASE MODEL; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HISTONE ACETYLATION; HUMAN; HYPERTENSION; KIDNEY PARENCHYMA; KIDNEY TUBULE ABSORPTION; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; RECEPTOR UPREGULATION; REVIEW; SALT SENSITIVE HYPERTENSION; SODIUM TRANSPORT; SYMPATHETIC TONE;

ANIMALS; HUMANS; HYPERTENSION; KIDNEY; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM;

EID: 84870508903     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-012-0284-5     Document Type: Review

References (39)

1. Fujita T, Henry W, Bartter F, Lake C, Delea C. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med. 1980;69:334-44.
2. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997;350:1734-7.
3. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science. 1991;252:1813-16.
4. Sanada H, Jones JE, Jose PA. Genetics of salt-sensitive hypertension. Curr Hypertens Rep. 2011;13:55-66.
5. Soundararajan R, Melters D, Shih IC, Wang J, Pearce D. Epithelial sodium channel regulated by differential composition of a signaling complex. Proc Natl Acad Sci U S A. 2009;106:7804-9.
6. Diakov A, Korbmacher C. A novel pathway of epithelial sodium channel activation involves a serum-and glucocorticoid-inducible kinase consensus motif in the C terminus of the channel's alphasubunit. J Biol Chem. 2004;279:38134-42.
7. Thomas SV, Kathpalia PP, Rajagopal M, Charlton C, Zhang J, Eaton DC, et al. Epithelial sodium channel regulation by cell surface-associated serum-and glucocorticoid-regulated kinase 1. J Biol Chem. 2011;286:32074-85.
8. Ring AM, Cheng SX, Leng Q, Kahle KT, Rinehart J, Lalioti MD, et al. WNK4 regulates activity of the epithelial Na+channel in vitro and in vivo. Proc Natl Acad Sci U S A. 2007;104:4020-24.
9. Pearce D, Kleyman TR. Salt, sodium channels, and SGK1. J Clin Invest. 2007;117:592-5.
10. Zhang W, Xia X, Reisenauer MR, Rieg T, Lang F, Kuhl D, et al. Aldosterone-induced Sgk1 relieves Dot1a-Af9-mediated transcriptional repression of epithelial Na+channel alpha. J Clin Invest. 2007;117:773-83.
11. Soundararajan R, Pearce D, Ziera T. The role of the ENaCregulatory complex in aldosterone-mediated sodium transport. Mol Cell Endocrinol. 2012;350:242-7.
12. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-17.
13. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309-21.
14. Zennaro MC, Souque A, Viengchareun S, Poisson E, Lombes M. A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action.Mol Endocrinol. 2001;15:1586-98.
15. Mihailidou AS, Le Loan TY, Mardini M, Funder JW. Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension. 2009;54:1306-12.
16. Wang H, Shimosawa T, Matsui H, Kaneko T, Ogura S, Uetake Y, et al. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions. J Hypertens. 2008;26:1453-62.
17. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, et al. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease.NatMed. 2008;14:1370-6. This is the original paper that reported rac1 activate MR independent from aldosterone in the kidney, and this aldosterone-independent MR activation causes renal dysfunction.
18. Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptordependent pathway. J Clin Invest. 2011;121:3233-43. This paper reported that rac1-mediated MR activation causes salt-sensitive hypertension in several rodent model.
19. Rapp JP, Garrett MR, Deng AY. Construction of a double congenic strain to prove an epistatic interaction on blood pressure between rat chromosomes 2 and 10. J Clin Invest. 1998;101:1591-5.
20. GarrettMR, Zhang X, Dukhanina OI, Deng AY, Rapp JP. Two linked blood pressure quantitative trait loci on chromosome 10 defined by dahl rat congenic strains. Hypertension. 2001;38:779-85.
21. Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, Guan KL. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science. 2000;290:144-7.
22. Ono A, Kuwaki T, Kumada M, Fujita T. Differential central modulation of the baroreflex by salt loading in normotensive and spontaneously hypertensive rats. Hypertension. 1997;29:808-14.
23. Fujita T, Sato Y. Role of hypothalamic-renal noradrenergic systems in hypotensive action of potassium. Hypertension. 1992;20:466-72.
24. Leenen FH, Ruzicka M, Huang BS. The brain and salt-sensitive hypertension. Curr Hypertens Rep. 2002;4:129-35.
25. Feng D, Yang C, Geurts AM, Kurth T, Liang M, Lazar J, et al. Increased expression of NAD(P)H oxidase subunit p67(phox) in the renal medulla contributes to excess oxidative stress and saltsensitive hypertension. Cell Metab. 2012;15:201-8.
26. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation. 2004;109:2357-62.
27. Fujita M, Ando K, Kawarazaki H, Kawarasaki C, Muraoka K, Ohtsu H, et al. Sympathoexcitation by brain oxidative stress mediates arterial pressure elevation in salt-induced chronic kidney disease. Hypertension. 2012;59:105-12.
28. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903-9.
29. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275-81.
30. Lohmeier TE, Tillman LJ, Carroll RG, Brown AJ, Guyton AC. Malignant hypertensive crisis induced by chronic intrarenal norepinephrine infusion. Hypertension. 1984;6:I177-82.
31. Guild SJ, Eppel GA, Malpas SC, Rajapakse NW, Stewart A, Evans RG. Regional responsiveness of renal perfusion to activation of the renal nerves. Am J Physiol Regul Integr Comp Physiol. 2002;283: R1177-86.
32. DiBona GF. Neural control of the kidney:past, present and future. Hypertension. 2003;41:621-4.
33. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, et al. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab. 2011;13:469-75. It has been postulated that renal rather than cardiac or vascular AT1 receptor plays an important role in hypertension by these authors. In this paper, they precisely investigated the AT1 receptor at proximal tubule increases sodium resorption to induce volumedependent hypertension.
34. Kahle KT, Ring AM, Lifton RP. Molecular physiology of the WNK kinases. Annu Rev Physiol. 2008;70:329-55. This is a comprehensive review of WNK kinase.
35. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, et al. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107-12.
36. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, et al. Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet. 2006;38:1124-32.
37. O'Reilly M, Marshall E, Macgillivray T, Mittal M, Xue W, Kenyon CJ, et al. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo. J Am Soc Nephrol. 2006;17:2402-13.
38. Li J, Wang DH. Function and regulation of epithelial sodium transporters in the kidney of a salt-sensitive hypertensive rat model. J Hypertens. 2007;25:1065-72.
39. Mu S, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, et al. Epigenetic modulation of the renal beta-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med. 2011;17 (5):573-80. This paper showed that beta2 receptor-mediated HDAC8 inhibition leads to suppression of WNK4 and stimulates NCC to cause salt-sensitive hypertension.